Michael O. Sullivan - Dec 16, 2021 Form 4 Insider Report for ORAGENICS INC (OGEN)

Role: Interim PEO, CFO
Signature: /s/ Mark A. Catchur, as Attorney-in-Fact for Michael O. Sullivan
Stock symbol: OGEN
Transactions as of: Dec 16, 2021
Transactions value $: $0
Form type: 4
Date filed: 12/17/2021, 04:13 PM
Next filing: Mar 30, 2022

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	OGEN	Employee Stock Option (Right to Buy)	Award	$0	+150K		$0.00	150K	Dec 16, 2021	Common Stock	150K	$0.49	Direct	F1

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	Represents an annual award of options to purchase shares of the Company's common stock under the Company's 2012 Equity Incentive Plan, as amended that vest evenly in three tranches. One third of the options vest on the first anniversary of the grant date, the second third of the options vest on the second anniversary of the grant date and the final third vest on the third anniversary of the grant date. The option exercise price is the closing price on the date of the grant, December 16, 2021.

Content

Represents an annual award of options to purchase shares of the Company's common stock under the Company's 2012 Equity Incentive Plan, as amended that vest evenly in three tranches. One third of the options vest on the first anniversary of the grant date, the second third of the options vest on the second anniversary of the grant date and the final third vest on the third anniversary of the grant date. The option exercise price is the closing price on the date of the grant, December 16, 2021.